Success Metrics

Clinical Success Rate
100.0%

Based on 19 completed trials

Completion Rate
100%(19/19)
Active Trials
0(0%)
Results Posted
100%(19 trials)

Phase Distribution

Ph phase_2
4
21%
Ph phase_1
7
37%
Ph phase_3
8
42%

Phase Distribution

7

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
7(36.8%)
Phase 2Efficacy & side effects
4(21.1%)
Phase 3Large-scale testing
8(42.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

19 of 19 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Completed(19)

Detailed Status

Completed19

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 17 (36.8%)
Phase 24 (21.1%)
Phase 38 (42.1%)

Trials by Status

completed19100%

Recent Activity

0 active trials
Showing 5 of 19
completedphase_2

A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

NCT01001104
completedphase_3

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

NCT01558271
completedphase_2

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

NCT00734474
completedphase_2

A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes

NCT01149421
completedphase_3

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

NCT01468181
View all 19 trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT01001104Phase 2

A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

Completed
NCT01558271Phase 3

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Completed
NCT00734474Phase 2

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Completed
NCT01149421Phase 2

A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes

Completed
NCT01468181Phase 3

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Completed
NCT01064687Phase 3

A Study in Participants With Type 2 Diabetes Mellitus

Completed
NCT01126580Phase 3

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)

Completed
NCT01075282Phase 3

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)

Completed
NCT00630825Phase 2

A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus

Completed
NCT01584232Phase 3

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

Completed
NCT01624259Phase 3

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

Completed
NCT01324388Phase 1

A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

Completed
NCT01191268Phase 3

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)

Completed
NCT01250834Phase 1

LY2189265 and Atorvastatin Interaction Study

Completed
NCT01215968Phase 1

A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus

Completed
NCT01408888Phase 1

A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

Completed
NCT01253304Phase 1

A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment

Completed
NCT01300260Phase 1

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Completed
NCT01301092Phase 1

A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.

Completed

All 19 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
19